Adipocytokines and cd34+ progenitor cells in alzheimer's disease

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Bigalke, Boris ^a,b   Schreitmüller, Brigitte ^c   Sopova, Kateryna ^a   Paul, Angela ^a   Stransky, Elke ^c   Gawaz, Meinrad ^a   Stellos, Konstantinos ^a   Laske, Christoph ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; CD34 ANTIGEN;

ADIPONECTIN BLOOD LEVEL; AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CD34+ PROGENITOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LEPTIN BLOOD LEVEL; MALE; MINI MENTAL STATE EXAMINATION; PROTEIN BLOOD LEVEL; STEM CELL; UPREGULATION; BLOOD; CELL COUNT; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

ADIPONECTIN; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD34; CELL COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 79957449971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020286     Document Type: Article

References (44)

1. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, et al. (2009) Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging. JAMA 302: 2565-2572.
2. Becker-Barroso E, (2005) More support for vascular basis of Alzheimer's disease. Lancet Neurol 4: 598-599.
3. Tezapsidis N, Johnston JM, Smith MA, Ahford JW, Casadesus G, et al. (2009) Leptin: a novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis 16: 731-740.
4. Bigalke B, Stellos K, Geisler T, Seizer P, Mozes V, et al. (2010) High plasma levels of adipocytokines are associated with platelet activation in patients with coronary artery disease. Platelets 21: 11-9.
5. Giordano V, Peluso G, Iannuccelli M, Benatti P, Nicolai R, et al. (2007) Systemic and Brain Metabolic Dysfunction as a New Paradigm for Approaching Alzheimer's Dementia. Neurochem Res 32: 555-567.
6. Blennow K, de Leon MJ, Zetterberg H, (2006) Alzheimer's disease. Lancet 368: 387-403.
7. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, et al. (2006) Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 48: 1155-62.
8. Laske C, Leyhe T, Stransky E, Eschweiler GW, Bueltmann A, et al. (2008) Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease. J Psychiatr Res 42: 746-51.
9. Laske C, Stellos K, Eschweiler GW, Leyhe T, Gawaz M, (2008) Decreased CXCL12 (SDF-1) Plasma Levels in Early Alzeheimer's Disease. A Contribution to a Deficient Hematopoietic Brain Support? J Alzheimers Dis 15: 83-95.
10. Stellos K, Panagiota V, Sachsenmaier S, Trunk T, Straten G, et al. (2010) Increased circulating CD34+/CD133+ progenitor cells in Alzheimer's disease patients with moderate to severe dementia: evidence for vascular repair and tissue regeneration? J Alzheimers Dis 19: 591-600.
11. Xu Q, (2007) Progenitor cells in vascular repair. Curr Opin Lipidol 18: 534-9.
12. Shibata R, Numaguchi Y, Matsushita K, Sone T, Kubota R, et al. (2008) Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction. Am J Cardiol 101: 1712-5.
13. Tobler K, Freudenthaler A, Baumgartner-Parzer SM, Wolzt M, Ludvik B, et al. (2010) Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes (Lond) 34: 687-700.
14. Wolk R, Deb A, Caplice NM, Somers VK, (2005) Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 183: 131-9.
15. Salmina AB, Inzhutova AI, Malinovskaya NA, Petrova MM, (2010) Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control. J Alzheimers Dis 22: 17-36.
16. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-21.
17. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355: 1199-209.
18. Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, et al. (2006) Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 27: 2300-9.
19. Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, et al. (2008) Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 29: 649-57.
20. Broedl UC, Lebherz C, Lehrke M, Stark R, Greif M, et al. (2009) Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS ONE 4: e4733.
21. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361: 226-8.
22. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I, (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33.
23. Fantuzzi G, (2008) Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121: 326-30.
24. Dubey L, Zeng H, Hashmi S, Hongjie W, Tao H, (2008) Association of plasma leptin levels and complexity of the culprit lesion in patients with unstable angina. Int J Cardiol 126: 183-9.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 30-4.
26. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-Mental-State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-98.
27. Stellos K, Bigalke B, Langer H, Geisler T, Schad A, et al. (2009) Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. Eur Heart J 30: 584-93.
28. Valerio A, Dossena M, Bertolotti P, Betoni F, Sarnico H, et al. (2009) Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-κB/c-Rel-dependent transcription. Stroke 40: 610-17.
29. Marousi SG, Theodorou GL, Karakantza M, Zampakis P, Papathanasopoulos P, et al. (2009) Acute post-stroke adiponectin in relation to stroke severity, progression and 6 month functional outcome. Neurol Res [epub ahead of print].
30. Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, et al. (1996) Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 93: 14564-8.
31. Schroeter MR, Leifheit M, Sudholt P, Heida NM, Dellas C, et al. (2008) Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 103: 536-44.
32. Umemoto Y, Tsuji K, Yang FC, Ebihara Y, Kaneko A, et al. (1997) Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood 90: 3438-43.
33. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y, (2001) Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98: 6390-5.
34. Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, et al. (1998) Biological action of leptin as an angiogenic factor. Science 281: 1683-6.
35. Garza JC, Guo M, Zhang W, Lu XY, (2008) Leptin increases adult hippocampal neurogenesis in vivo and in vitro. J Biol Chem 2008 283: 18238-47.
36. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, et al. (2009) Age, neuropathology, and dementia. N Engl J Med 360: 2302-09.
37. Hara K, Yamauchi T, Imai Y, Manabe I, Nagai R, et al. (2007) Reduced adiponectin level is associated with severity of coronary artery disease. Int Heart J 48: 149-53.
38. Wallander M, Söderberg S, Norhammar A, (2008) Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Diabet Med 25: 949-55.
39. Fewlass DC, Noboa K, Pi-Sunyer X, Johnston JM, Yan SD, et al. (2004) Obesity-related leptin regulates Alzheimer's Aβ. FASEB J 18: 1870-8.
40. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, et al. (2008) Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc 56: 111-6.
41. Gunstad J, Spitznagel MB, Keary TA, Glickman E, Alexander T, et al. (2008) Serum leptin levels are associated with cognitive function in older adults. Brain Res 1230: 233-6.
42. Marwarha G, Dasari B, Prasanthi JR, Schommer J, Ghribi O, (2010) Leptin reduces the accumulation of Aβ and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J Alzheimers Dis 19: 1007-19.
43. Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, et al. (2010) Chronic Leptin Supplementation Ameliorates Pathology and Improves Cognitive Performance in a Transgenic Mouse Model of Alzheimer's Disease. J Alzheimers Dis [Epub ahead of print].
44. Buerger K, Ernst A, Ewers M, Uspenskaya O, Omerovic M, et al. (2009) Blood-based microcirculation markers in Alzheimer's disease- diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. Biol Psychiatry 65: 979-84.